Featured Research

from universities, journals, and other organizations

Yogurt organisms and cancer research

Date:
March 19, 2013
Source:
Cancer Institute of New Jersey
Summary:
One may not think of probiotics -- like those found in yogurt that promote good digestive health -- as a weapon used in the fight against cancer. But that is the focus of investigators who are examining the effectiveness of probiotics as they relate to the outcomes of bone marrow transplant for patients with blood cancers.

One may not think of probiotics -- like those found in yogurt that promote good digestive health -- as a weapon used in the fight against cancer. But that is the focus of investigators at The Cancer Institute of New Jersey, who are examining the effectiveness of probiotics as they relate to the outcomes of bone marrow transplant for patients with blood cancers. The Cancer Institute of New Jersey is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.

Related Articles


Some patients with leukemia, lymphoma and myeloma are treated with an "allogeneic" bone marrow transplant where the donor is a blood relative or is unrelated but has the same tissue type. Donated cells can generate an immune attack against cancer cells in the patient, but they can also attack normal healthy cells and tissues. This attack, known as "graft-versus-host disease (GVHD)," is one of the major complications of transplantation and occurs in the gastrointestinal (GI) tract in 25 to 40 percent of patients who undergo the allogeneic procedure.

When the GI tract malfunctions, bacteria in the colon can invade the body and cause severe infections that activate the immune system. GVHD can then progress to the liver and other organs. Probiotics are known to reduce the growth of certain types of bacteria. Investigators at The Cancer Institute of New Jersey, who have already determined the probiotic lactobacillus GG is safe in relation to GVHD, are now exploring its effectiveness as part of the "PERFECT" (Probiotic Enteric Regimen For Easing Complications of Transplant) trial. The research is being led by Roger Strair, MD, PhD, chief of hematologic malignancies/hematopoietic stem cell transplantation at The Cancer Institute of New Jersey, and has received generous support from the Steven and Beverly Rubenstein Charitable Foundation, Inc.

"This funding from the Steven and Beverly Rubenstein Charitable Foundation allows us to build on our previous findings without interruption. By further exploring the effects of probiotics on graft-versus-host-disease, we may be able to identify methods of preventing infection. We are grateful for their support," noted Dr. Strair, professor of medicine at UMDNJ-Robert Wood Johnson Medical School.

Andrew Rubenstein is a trustee and manager of the Steven and Beverly Rubenstein Charitable Foundation -- named for his parents who instilled in him at a young age the importance of giving back. With father Steven having passed away of acute myeloid leukemia, Andrew Rubenstein felt a connection to Strair's work. "My father's treatment stemmed from innovative research that was being conducted at the time. By participating in that treatment, he understood the importance of advancing those latest findings. Through our foundation's support of Dr. Strair's research, we hope to keep such advances moving forward," he said.


Story Source:

The above story is based on materials provided by Cancer Institute of New Jersey. Note: Materials may be edited for content and length.


Cite This Page:

Cancer Institute of New Jersey. "Yogurt organisms and cancer research." ScienceDaily. ScienceDaily, 19 March 2013. <www.sciencedaily.com/releases/2013/03/130319144150.htm>.
Cancer Institute of New Jersey. (2013, March 19). Yogurt organisms and cancer research. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2013/03/130319144150.htm
Cancer Institute of New Jersey. "Yogurt organisms and cancer research." ScienceDaily. www.sciencedaily.com/releases/2013/03/130319144150.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins